30 ACTUAT umeclidinium 0.0625 MG/ACTUAT Dry Powder Inhaler [Incruse]
RxNorm concept 1539885, branded drug (sbd). Prescribable name: Incruse Ellipta 62.5 MCG/INHAL Dry Powder Inhaler, 30 Blisters.
- RxCUI
- 1539885
- Term type
- Branded drug (SBD)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/1539885 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Other names
Incruse Ellipta (umeclidinium 62.5 MCG) per ACTUAT Dry Powder Inhaler, 30 ACTUAT; Incruse Ellipta 62.5 MCG/INHAL Dry Powder Inhaler, 30 Blisters
Related concepts
- umeclidinium 0.0625 MG/ACTUAT (SCDC, consists of)
- umeclidinium 0.0625 MG/ACTUAT [Incruse] (SBDC, consists of)
- Dry Powder Inhaler (DF, has dose form)
- Incruse (BN, has ingredient)
- 30 ACTUAT umeclidinium 0.0625 MG/ACTUAT Dry Powder Inhaler (SCD, tradename of)
Linked data
NDCs
NDC-11s RxNorm links to this concept; linked ones open their FDA product.
Use it
Look up 1539885 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/1539885 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 1539885. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.